Family Nurture Intervention in the NICU at The Valley Hospital
NCT ID: NCT03267043
Last Updated: 2023-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2017-10-20
2020-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that FNI will improve: i) neonatal electroencephalographic activity ii) maternal caregiving and wellbeing (psychological and physiological, and iii) infant behavior and neurodevelopment at 18 months corrected age (CA).
The two-phase effectiveness study aims to:
* Phase 1 - Examine the existing Standard Care Approximately 35 infants and their mothers
* Phase 2 - Examine effectiveness by implementing FNI unit-wide so that every baby receives the intervention Approximately 35 infants and their mothers
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Family Nurture Intervention in the NICU
NCT02710474
Family Nurture Intervention (FNI) in Neonatal Intensive Care Unit (NICU)
NCT01439269
Family Nurture Intervention in the CHoNJ NICU
NCT02352142
Early Behavioral Intervention for Preterm Infants
NCT02379130
Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care
NCT00914108
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators wish to conduct an effectiveness trial to evaluate if the family nurture intervention's findings can be replicated on a unit-wide level. This effectiveness trial will take place over two parts. There will be two groups; standard care (SC) and intervention (FNI). Phase 1 of the effectiveness study will evaluate the standard care (SC) group in the unit as a baseline measurement and point of comparison to determine if unit-wide FNI reproduces its prior findings (Phase 2). The standard care group (Phase 1) will receive the current standard of care in the NICU. In Phase 2, FNI will be implemented unit-wide, but infants born between 26 weeks and 0 days to 33 weeks 6 days gestation will be eligible to be enrolled into the study. In addition to receiving standard care, patients enrolled during phase 2 will receive added interventions from the trained FNI nursing staff. These added interventions will include supporting the parents and facilitating contact between mother and infant during their infant's NICU stay.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Care
Participants enrolled in Phase 1 will be receiving the current standard of care in the NICU at The Valley Hospital.
Standard Care
Established routine care provided on the NICU floor by specially trained health care professionals.
Family Nurture Intervention (FNI)
Participants enrolled in Phase 2 will be receiving family nurture intervention (FNI) that focuses on supporting the parents and facilitating emotional connection between mother and infant during the infant's NICU stay.
Family Nurture Intervention (FNI)
Subjects will be guided by the nursing staff through an enhanced program of mother/infant interactions, which include skin-to-skin holding.
Standard Care - Case Studies
Participants enrolled as case studies in Phase 1 will be receiving the current standard of care in the NICU at The Valley Hospital. These participants will be those who fall outside the inclusion criteria.
Standard Care
Established routine care provided on the NICU floor by specially trained health care professionals.
FNI - Case Studies
Participants enrolled in Phase 2 will be receiving family nurture intervention (FNI) that focuses on supporting the parents and facilitating emotional connection between mother and infant during the infant's NICU stay. These fall outside the inclusion criteria but act as a comparator to the case studies of Phase 1.
Family Nurture Intervention (FNI)
Subjects will be guided by the nursing staff through an enhanced program of mother/infant interactions, which include skin-to-skin holding.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Family Nurture Intervention (FNI)
Subjects will be guided by the nursing staff through an enhanced program of mother/infant interactions, which include skin-to-skin holding.
Standard Care
Established routine care provided on the NICU floor by specially trained health care professionals.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* infant is a singleton or twin
Exclusion Criteria
* severe congenital anomalies including chromosomal anomalies
* ultrasound evidence of large parenchymal hemorrhagic infarction (\>2 cm, intraventricular hemorrhage grade 3 or 4)
* infant cardiac anomalies
* mother has known history of substance abuse, severe psychiatric illness or psychosis
* mother and/or infant has a medical condition that precludes intervention components
* mother and/or infant has a contagion that endangers other participants in the study
26 Weeks
34 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Martha G Welch
Associate Professor of Psychiatry (in Pediatrics and Pathology and Cell Biology)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martha G Welch, MD
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Valley Hospital
Ridgewood, New Jersey, United States
Morgan Stanley Children's Hospital of New York (MSCHONY)
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAAR4899
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.